Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-019763
Filing Date
2022-05-18
Accepted
2022-05-18 14:59:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20004267x1_defa14a.htm DEFA14A 43876
2 logo_compasstherapeutics.jpg GRAPHIC 52578
  Complete submission text file 0001140361-22-019763.txt   117205
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39696 | Film No.: 22938636
SIC: 2836 Biological Products, (No Diagnostic Substances)